Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2022 Apr 28;13:910421. doi: 10.3389/fphar.2022.910421

Corrigendum: Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway

Shengqiang Li 1, Zhen Lei 1, Xiaomei Yang 1, Meng Zhao 1, Yonghao Hou 1, Di Wang 2, Shuhai Tang 1, Jingxin Li 3,*, Jingui Yu 1,*
PMCID: PMC9096490  PMID: 35571131

In the published article, there was an error regarding the affiliation for Jingxin Li. The full designation for affiliation 3 is “Department of Physiology, School of Basic Medical Science, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China”.

There was an error in the Funding statement. The correct name for the third listed funder is “Key Research and Development Program of Shandong Province (No. 2018GSF118079)”.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES